Skip to main content

America’s poor diet made Covid much worse. Washington isn’t paying attention. – POLITICO

Just a few days later, Boris Johnson gave a speech at the Conservative Party Conference alluding to his anti-obesity campaign by striking a personal chord: “I had a very common underlying condition: My friends, I was too fat.” The prime minister also mentioned he’d since lost 26 pounds. He went on to outline a vision for the future of Britain that included a healthier population, with more biking and walking.

Stateside, the U.S. government was still not raising the alarm about the link between rampant metabolic disease and greater risk. It was never part of White House messaging on the virus and the suite of policies needed to respond to the crisis — something that didn’t change when President Joe Biden took the reins, either.

“It’s not central to the discussion at all,” said Dan Glickman, who served as agriculture secretary during the Clinton administration and is now a senior fellow at the Bipartisan Policy Center.

Glickman noted that the country’s leading voices on coronavirus, including Anthony Fauci, don’t focus on underlying conditions and what could be done about them long term. Instead, the focus is solely on vaccines, which have been proven to be safe and effective.

“They hardly ever talk about prevention,” Glickman said. “It’s missing. It’s a gigantic gap in the discussion about how health care relates to Covid and how it relates to the prevention of disease.”

As the pandemic heads into its third year, the connection to diet-related diseases and the overall vulnerability of the American population is a theme that remains absent at the highest levels of government. The only high-level Biden administration official who routinely talks about the issue is Agriculture Secretary Tom Vilsack — and he brings it up often.

Vilsack, who’s serving in the role for a second time after eight years during the Obama administration, likes to point out in his speeches, for example, that the government now spends more treating diabetes than the entire budget of the USDA, which is about $150 billion.

In an interview with POLITICO, Vilsack noted that more than half of the $380 billion per year spent treating just cardiovascular disease, cancer and diabetes is now picked up by the government, including through programs like Medicare and Medicaid.

“Ironically, if you could eliminate those costs you would be able to afford a $3.5 trillion Build Back Better bill [without pay-fors],” he said.

“It’s a significant issue that requires elevation,” Vilsack said. “We’re moving the dials that we can move at USDA. I think, however, it takes more than that. I think it takes multiple departments focused on this and multiple leaders saying this is an issue that requires some attention.”

⧫⧫⧫

Dealing with diet-related diseases hasn’t been top of mind in Congress, either. For example, there’s a bipartisan bill to require Medicare to cover medications and more types of specialists to help treat obesity. The legislation has been introduced repeatedly since 2013, the year the American Medical Association formally recognized obesity as a disease, but has not gotten much traction even as major Covid aid bills have moved through Congress.

Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School who is a key advocate for the bill, said the pandemic has sparked much more interest among lawmakers and staff, but it hasn’t yet translated into legislative action.

One of the biggest challenges, she said, is that most people still do not understand obesity is a complex disease, not something that can be blamed on or fixed by personal choices, and it often requires multidisciplinary treatment that many people do not have access to.

“We aren’t taught about obesity,” Stanford said, referring to a lack of education in medical schools. “If doctors don’t understand obesity, why would the general public? Why would policymakers?”

Last month, the Government Accountability Office released a report on the state of the country’s response to diet-related diseases, concluding that there are scattered efforts across the federal government, but there isn’t enough coordination, nor an overarching plan.

“Congress should consider identifying and directing a federal entity to lead development and implementation of a federal strategy for diet-related efforts aimed at reducing Americans’ risk of chronic health conditions,” the GAO recommended.

Jerold Mande, a professor at the Harvard T.H. Chan School of Public Health and a fellow at Tufts University, who served in high-level positions at FDA and USDA in the H.W. Bush, Clinton and Obama administrations, said the report should be a gut check. “We’re not serious,” he said. “You look at the GAO report, and you conclude we’re not serious.”

The GAO identified just six “regulatory” actions the government has taken to try to combat diet-related diseases, but those policies are “largely educational” Mande noted, citing the Nutrition Facts label, which he helped design and launch during the H.W. Bush administration.



from WordPress https://ift.tt/3GCPNTJ
via IFTTT

Comments

Popular posts from this blog

Covid-19 News: F.D.A. Panel to Meet This Week on Moderna and J. & J. Boosters – The New York Times

Image A vaccination site in Spain, where the health regulator approved the use of third Covid-19 vaccination shots for immunocompromised people in September. Credit… Zowy Voeten/Getty Images Severely or moderately immunocompromised people who have been vaccinated should be offered an additional dose of the seven coronavirus vaccines the World Health Organization has authorized, an advisory committee recommended on Monday. People whose immune systems are diminished should get another shot if they initially received vaccines made by Pfizer-BioNTech, Moderna, AstraZeneca, the Serum Institute of India, Johnson & Johnson, Sinopharm and Sinovac, members of the Strategic Advisory Group of Experts on Immunization told reporters on a call on Monday. Dr. Alejandro Cravioto, the committee’s chair, said that people with compromised immune systems “need a third dose as an additional priming process so that they’re fully protected.” The officials also recommended a third vaccine ...

COVID-19 live updates: Pfizer to seek approval for adult boosters, source says – WOKV

NEW YORK — As the COVID-19 pandemic has swept the globe, more than 5 million people have died from the disease worldwide, including over 756,000 Americans, according to real-time data compiled by Johns Hopkins University’s Center for Systems Science and Engineering. Just 68.4% of Americans ages 12 and up are fully vaccinated against COVID-19, according to data from the U.S. Centers for Disease Control and Prevention. Latest headlines: -US surgeon general releases guide to combating COVID-19 vaccine misinformation -Pfizer to request OK for boosters to all adults: Source -US reopens borders to vaccinated travelers Here’s how the news is developing. All times Eastern. Nov 09, 2:42 pm Aaron Rodgers: ‘To anybody who felt misled … I take full responsibility’ Green Bay Packers quarterback Aaron Rodgers says he takes full responsibility for anyone who felt mislead by his comments about his vaccination status. “I do realize I am a role model,” Rodgers said on “The Pat McAfee Show” Tu...

The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday. – The New York Times

Coronavirus Updates Aug. 21, 2021 Updated  Aug. 21, 2021, 10:11 p.m. ET Aug. 21, 2021, 10:11 p.m. ET Pfizer vaccines were administered at the St. John Chrysostom Catholic Parish in The Bronx on Sunday. Credit… James Estrin/The New York Times The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning. Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time. An F.D.A. spokeswoman declined to comment. The agency had recently set an unofficial deadline for approval of around Labor Day. The approval is expected to ...